The Aging-as-Disease Reframe
Redefine aging as a treatable disease to unlock funding, research, and solutions
Sinclair argues that the single greatest barrier to extending healthy human lifespan is not scientific but definitional: because aging is classified as a natural process rather than a disease, it receives almost no dedicated funding, no drug development pipeline, and no insurance reimbursement for treatment. This classification is based entirely on the fact that aging affects more than 50 percent of the population -- a distinction Sinclair calls arbitrary and backward.
Aging fulfills every medical criterion for disease classification: it results in physical decline, limits quality of life, and has a specific pathology (epigenetic information loss). Yet the conventional medical framework treats it as inevitable and irreversible, channeling all resources into downstream symptoms while ignoring the upstream cause. Sinclair draws a parallel to how pneumonia, influenza, and tuberculosis were once accepted as inevitable -- until framing changed and medical innovation followed.
The practical power of this reframe extends far beyond personal mindset. When individuals, institutions, and governments begin treating aging as a disease, it changes what gets funded, what drugs get developed, what insurance covers, and what doctors are trained to address. The economic case is overwhelming: an antiaging compound extending healthy years by a decade would cost a mere fraction of treating the diseases it prevents.
- Aging meets every criterion for disease classification except affecting more than 50 percent of the population
- The classification of aging as 'natural' prevents funding, drug development, and insurance coverage
- Treating aging upstream would be orders of magnitude cheaper than treating downstream diseases
- Historical precedent shows that diseases once considered inevitable became treatable once reframed
- Words, definitions, and framing matter -- they determine what gets researched, funded, and solved
- Examine Your Own AssumptionsNotice how often you or those around you say things like 'that's just what happens when you get old' or 'it's just the way it goes.' Sinclair's grandmother said these words, and he argues they represent a surrender that prevents action. Replace fatalism with the understanding that aging has a specific, addressable mechanism.
- Learn the Economic ArgumentUnderstand that the US spends hundreds of billions annually fighting cardiovascular disease and cancer, yet eliminating either would add only 1.5 to 2.1 years to average lifespan. An aging intervention extending healthy life by a decade would cost a fraction of current disease-by-disease spending. Use these numbers in conversations to shift perspectives.
- Apply the Reframe PersonallyBegin treating your own aging as something to be managed and slowed rather than passively accepted. Seek out healthcare providers who understand longevity medicine. Track your biological age rather than just chronological age. Make health decisions based on the understanding that decline is modifiable, not fated.
- Advocate SystemicallySupport organizations working to have aging classified as a disease by the WHO and other health bodies. Advocate for increased funding for aging research. Encourage employers to invest in preventive health rather than only treating disease. Vote for policies that prioritize healthspan over end-of-life care.
Werner syndrome causes people to look and feel 80 when they are in their 40s. When Sinclair studied it at MIT, no one questioned that it was a disease worthy of research funding. No one told Werner patients that their accelerated aging was natural or inevitable. Yet the same biological process happening to every human over a longer timeframe was dismissed as not-a-disease simply because it affected everyone.
Sinclair's frustration with the aging-as-natural classification grew from his work on Werner syndrome, a condition that causes people to look 80 when they are 40. No one questioned that Werner syndrome was a disease worth studying. Yet the same process happening to everyone over a longer timeframe was dismissed as inevitable. A 2005 RAND study by Dana Goldman showed that an antiaging compound extending healthy life by a decade would cost only $8,790 per life-year gained, compared to $498,809 for a cancer treatment -- yet aging research received negligible funding.